Comparison of tyrosine hydroxylase and dopamine-beta-hydroxylase inhibition with the effects of various 6-hydroxydopamine treatments on d-amphetamine induced motor activity.
D000818:Animals; D001921:Brain / Q000201:enzymology; D001923:Brain Chemistry / Q000187:drug effects; D003891:Desipramine / Q000494:pharmacology; D003913:Dextroamphetamine / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism; D004299:Dopamine beta-Hydroxylase / Q000037:antagonists & inhibitors*; D006801:Humans; D006834:Hydrazines / Q000494:pharmacology; D006892:Hydroxydopamines / Q000494:pharmacology*; D007490:Iproniazid / Q000494:pharmacology; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects*; D009638:Norepinephrine / Q000378:metabolism; D010293:Pargyline / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology; D013239:Stereotyped Behavior / Q000187:drug effects; D013890:Thiourea / Q000494:pharmacology; D013997:Time Factors; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors*
D006834:Hydrazines; D006892:Hydroxydopamines; D008781:Methyltyrosines; D012110:Reserpine; D010293:Pargyline; D007490:Iproniazid; D014446:Tyrosine 3-Monooxygenase; D004299:Dopamine beta-Hydroxylase; D013890:Thiourea; D003891:Desipramine; D003913:Dextroamphetamine; D004298:Dopamine; D009638:Norepinephrine